In Conversation

"Our biggest bet to date was putting in place a strategy that would see us become an international company."

"National production is doing well. It represents at least 70 percent of the volume sold on the domestic market."

"I have perceived a really strong level of collaboration between all stakeholders; from industry and physicians to government and patients"

"Today mc PHARMA’s revenues, including those generated on behalf of our clients, place us as the second largest company in the Tunisian medical promotion field."

"The Tunisian pharmaceutical industry is one of the most important in the Arab world after that of Jordan."

Our goal is not to become much bigger, but smarter and more intelligent. We have to be even more focused and agile

"Vienna can be regarded as a center of excellence for plasma and hematology." Josef Weinberger

"Tunisia might be a small country geographically on the global scale; however, we never stopped considering it as a significant market with patients that rely on…

"The excellent work that our teams are doing we hope will continue to attract the eyes of headquarters when global R&D allocate their trials."

"In the past, antibiotics were a tough industry, and there was very little research done. What is happening now is that this is becoming a very…

"We are not running away from innovative drugs and, in fact, the NHIF allocates 60 percent of its pharmaceutical budget to innovative solutions"

"Due to my background as a chemist and years in the hospital setting, I saw room for improvement to develop novel innovative blood tests; therefore, ARCHIMEDlife…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here